The market for diabetes care products covers the spectrum of clinical medicine, including diagnostics,
biologics, and drugs. Several areas have strong growth potential and others, such as drugs to treat complications, represent large underserved markets for drugs primarily marketed to other populations.
Segmentation of patient populations in novel ways, such as diabetic candidates for
cardiovascular drugs, presents an excellent opportunity to expand markets and influence prescription practices in some markets. Scope and Methodology In addition to epidemiology of diabetes Type 1 and Type 2 in Germany, this market summary will examine the top line market numbers in each of the following…
